Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingchun Zhao
Institutions:
Shenyang Pharmaceutical University,
China Medical University,
General Hospital of Shenyang Military Region,
China Medical University
Observed institutions:
Shenyang Pharmaceutical University,
China Medical University,
General Hospital of Shenyang Military Region,
China Medical University
ORCID:
0000-0002-9468-1040
Observed ORCIDs:
0000-0002-9468-1040,
0000-0001-9256-9971
OpenAlex ID:
A5024048661
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease
2022
·
Wenjie Liu
, Limeng Wu
, et al.
·
European Journal of Medicinal Chemistry
·
50
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease
2021
·
Wenwu Liu
, Xin Liu
, et al.
·
European Journal of Medicinal Chemistry
·
47
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment
2022
·
Wenjie Liu
, Liting Tian
, et al.
·
Bioorganic Chemistry
·
26
Evodiamine: A Privileged Structure with Broad-ranging Biological Activities
2022
·
Wenwu Liu
, Qingchun Zhao
, et al.
·
Mini-Reviews in Medicinal Chemistry
·
25
Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects
2022
·
Caizhi Tian
, Shuoqi Huang
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
Notopterygium incisum roots extract (NRE) alleviates neuroinflammation pathology in Alzheimer’s disease through TLR4-NF-κB pathway
2024
·
Huilin Zhu
, Jie Liu
, et al.
·
Journal of Ethnopharmacology
·
20
TRPM8 and TRPA1 ideal targets for treating cold-induced pain
2024
·
Yiming Qi
, Hao Gong
, et al.
·
European Journal of Medicinal Chemistry
·
18
Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property
2022
·
Wenwu Liu
, Limeng Wu
, et al.
·
Bioorganic Chemistry
·
17
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
2022
·
Limeng Wu
, Wenjie Liu
, et al.
·
European Journal of Medicinal Chemistry
·
15
Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors
2022
·
Yaoguang Huang
, Wenwu Liu
, et al.
·
Bioorganic Chemistry
·
12
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway
2022
·
Xiaochun Qin
, Mingyue Liu
, et al.
·
Frontiers in Oncology
·
8
PDF
Chemical constituents of Gelsemium elegans Benth.
2007
·
Qingchun Zhao
·
Zhongguo yaowu huaxue zazhi
·
7
Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3
2024
·
Lijun Zhou
, Zhentong Qi
, et al.
·
European Journal of Medicinal Chemistry
·
6
Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity
2025
·
Xiaoxuan Song
, Xin Tong
, et al.
·
Bioorganic Chemistry
·
5
Discovery of novel oxindole derivatives as TRPA1 antagonists with potent analgesic activity for pain treatment
2024
·
Yiming Qi
, Hao Gong
, et al.
·
Bioorganic Chemistry
·
4
Identify the key genes and pathways of melatonin in age-dependent mice hippocampus regulation by transcriptome analysis
2024
·
Yujia Gu
, Jiayu Zhou
, et al.
·
Computational Biology and Chemistry
·
3
Harmine derivative ZLWH-38 ameliorates the therapeutic efficacy of colistin against XDR-Ab pneumonia by suppressing inflammatory responses
2025
·
Junjie Lin
, Xianghuan Liu
, et al.
·
International Immunopharmacology
·
2
UCP1-inspired mitochondrial uncouplers: Design, synthesis and thermogenic activity studies
2025
·
Hao Gong
, Yiming Qi
, et al.
·
Bioorganic Chemistry
·
2
New drugs approved by the FDA in 2025: Synthesis and clinical applications
2026
·
Wenjie Liu
, Wenjie Liu
, et al.
·
European Journal of Medicinal Chemistry
·
1
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer’s disease therapy
2026
·
Zhenshu Li
, Huanhua Chen
, et al.
·
Frontiers in Pharmacology
·
1
Structure-Based Discovery of HS34: A Highly Selective and Orally Bioavailable CDK9 Inhibitor for Triple-Negative Breast Cancer
2026
·
Yaoguang Huang
, Wenwu Liu
, et al.
·
Journal of Medicinal Chemistry
·
1
A novel DYRK1A inhibitor alleviates lipopolysaccharide-induced acute lung injury via suppressing inflammatory pathway
2026
·
Xi Zeng
, Lingyu Cui
, et al.
·
International Immunopharmacology
·
1
Extraction process of flavanone in Citrus aurantium L. by orthogonal design.
2013
·
Yin MingXiao
, Zhang Jinjie
, et al.
·
Shiyong yaowu yu linchuang
·
1
Corrigendum to “Effect and mechanism of novel HDAC inhibitor ZDLT-1 in colorectal cancer by regulating apoptosis and inflammation” [Int. Immunopharmacol. 143 (2024) 113333]
2026
·
Hefeng Geng
, Fangyuan Zheng
, et al.
·
International Immunopharmacology
PDF
ZDWX-25, a dual DYRK1A/GSK3β inhibitor, attenuates tau hyperphosphorylation and neuroinflammation in acute mouse models
2026
·
Weiyi Wang
, Yu Xing
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
33
Citation count:
295
H-index:
10
I10-index:
10
Year
Topic
Type